| Value | ₹418.0 Cr |
|---|
BSE filing, NSE: OMNI. Summary written from the filing by ALFA Finder's alert engine.
Omnitech Engineering Ltd: key numbers
- Share price
- ₹669.40
- Market cap
- ₹8,278 Cr
- Revenue (annual)
- ₹511.3 Cr
- Net profit (annual)
- ₹79.36 Cr
- P/E (TTM)
- 74.0×Sector 52.6×
- Promoter holding
- 74.19%+0.00% QoQ
- FII holding
- 3.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Omnitech Engineering Ltd
All →Omnitech Engineering Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹1,755.6 Mn (+40.5% YoY), PAT ₹305.7 Mn (+35.5%). H1 FY27 revenue ₹3,422.2 Mn (+50.0%), PAT ₹602.9 Mn (+117.0%). Order book ₹31,780 Mn.
Omnitech Engineering Q2 FY27 Results: Net Profit ₹30.6 Cr, Up 35.4% YoY
Omnitech Engineering Ltd reported revenue from operations of ₹175.6 Cr (+40.5% YoY) and net profit of ₹30.6 Cr (+35.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹30.6 Cr · +35.4% YoY
Omnitech Engineering Board Meeting Date
Omnitech Engineering intimated BSE and NSE of a board meeting on 4 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window stays closed until 48 hours after the results declaration.
Omnitech Engineering Bags New Order from Indian defence-sector organisations
Omnitech Engineering secured new commercial orders from Indian defence-sector organisations for precision-engineered components. These orders strengthen the company's aerospace and defence manufacturing portfolio.
- From
- Indian defence-sector organisations
Omnitech Engineering Capacity Expansion
Omnitech Engineering has entered the data centre infrastructure value chain, commencing commercial production for precision-engineered components following successful customer First Article approval.
Omnitech Engineering Other Announcement
The company has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Other other announcement announcements
All →Mankind Pharma Other Announcement
Mankind Pharma Limited received an ESG rating of 64.8 from SES ESG Research. This rating was independently assigned for FY26 based on publicly available information.
Moneyview Other Announcement
Moneyview Ltd has appointed Ankit Kumar Jain as Nodal Officer for the Investor Education and Protection Fund. This role handles claim verification and coordination with the IEPF Authority.
Mastek Other Announcement
Mastek Limited has announced a change in the corporate office address of its Registrar and Share Transfer Agent, KFin Technologies Limited. The change is effective December 1, 2026.
Desi Farms India Other Announcement
Desi Farms India Ltd has appointed M/s Ojha Agrawal & Associates as Statutory Auditors. The appointment fills a casual vacancy following the resignation of the previous auditors.
Faze Three Other Announcement
Faze Three Ltd files its quarterly shareholding pattern as of 30 September 2026. The filing notes 2,78,840 shares allotted to its ESOP trust on 11 August 2026.
Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Limited received approval from the Registrar of Companies to extend its 51st Annual General Meeting deadline. The meeting will now be held by December 31, 2026.